Orthostatic Hypotension

Lundbeck Neurogenic Orthostatic Hypotension protocol #16306A<- click for more information

Basic Eligibility Criteria:

  • 18 Years and older and able to stand
  • Clinical diagnosis of symptomatic orthostatic hypotension associated with Primary Autonomic Failure
  • Patients who are taking prescribed droxidopa therapy are eligible to participate in the study if they meet the other inclusion criteria and also have been on a stable dose of prescribed droxidopa for at least 2 weeks prior to the Screening Visit



If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Irina Gamerman, M.D., Clinical Research Manager, at [email protected]

Clinical Research Coordinator:


Micah Sy at [email protected]

You may also call 203.333.1151 and we will be happy to answer any of your questions.